2019-11-06 10:20

Presentation of Qlife on Stora Aktiedagen (Shareholder’s Day)

CEO Thomas Warthoe will present Qlife at Stora Aktiedagen (Shareholder’s Day) in Gothenburg on 4 November and in Stockholm on 25 November. Would you like to read more about the programme and how to sign up, see attached notification.

2021-01-07 08:00
Qlife CE-marks COVID-19 test

The current CE-mark applies to the professional use of the test platform Egoo.Health for sale on the European market.

2020-12-22 10:59
Qlife raises loans of SEK 15 million to strengthen working capital ahead of the upcoming market launch.

Qlife expects to CE mark its COVID-19 test for professional use in the Egoo.Health system within short.

2020-11-30 08:00
Qlife to increase decentralized testing of professional football in Denmark with Divisionsforeningen - Egoo.Health-platform placed in three clubs

Since May 2020, Qlife has been handling all testing for COVID-19 for professional football in Denmark.

2020-11-27 13:57
Qlife will not respond to preliminary rejection by the Danish Medicines Agency for COVID-19 test – focus on receiving CE-marking by year-end

On November 13, Qlife was informed that the Danish Medicines Agency (Lægemiddelstyrelsen) had rejected the application for temporay approval in Denmark “in the interest of health protection” for th

2020-11-24 08:45
Qlife receives order for COVID-19 tests to European Women’s Handball Championship 2020

”We will do our utmost to protect the participating players against the coronavirus”, says Frank Smith, Covid-19 Officer, European Handball Federation Euro 2020 “It requires testing with high preci

2020-11-19 11:30
Bulletin from the extraordinary shareholders’ meeting in Qlife Holding AB

Resolution on (A) employee option program; and (B) directed issue of warrants and approval of transfer of warrants

2020-11-18 11:44
QLIFE HOLDING AB INTERIM REPORT Q3, 2020

FINANCIAL SUMMARY - THIRD QUARTER 2020

2020-11-13 17:55
Qlife: application for temporary approval in Denmark "in the interest of health protection" receives preliminary rejection by the Danish Medicines Agency

In parallel to the ongoing process of preparing and putting together the dossier for the CE-mark, Qlife has submitted an application for placing the product on the market at this stage, as it offer

2020-11-03 09:03
Nomination Committee appointed for Qlife Holding's Annual General Meeting 2021

The Nomination Committee consists of the following persons, who together represent approximately 39 percent of the company's shares and votes.